DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: INOMAX

Summary for Tradename: INOMAX

Patents:15
Applicants:1
NDAs:1
Suppliers: see list1
drug
patent expirations by year for
 INOMAX

Pharmacology for Tradename: INOMAX

Drug ClassVasodilator
Physiological EffectVasodilation

Clinical Trials for: INOMAX

Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children
Status: Recruiting Condition: Acute Chest Syndrome; Sickle Cell Disease

Comparison of Inhaled Nitric Oxide and Oxygen in Patient Reactivity During Acute Pulmonary Vasodilator Testing
Status: Completed Condition: Idiopathic Pulmonary Arterial Hypertension; Congenital Heart Disease With Pulmonary Hypertension; Cardiomyopathy

Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver Transplantation
Status: Recruiting Condition: Liver Transplantation; Ischemia/Reperfusion Injury; Oxidative Injury

The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation
Status: Completed Condition: Congestive Heart Failure

Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion
Status: Not yet recruiting Condition: Hypertension, Pulmonary; Hemolysis

Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia
Status: Completed Condition: Pulmonary Disease

Phase II Evaluation of Exhaled Nitric Oxide (NO)
Status: Completed Condition: Lung Cancer

Inhaled Nitric Oxide (INO) In Hypoxic Respiratory Failure
Status: Withdrawn Condition: Hypoxic Respiratory Failure With Pulmonary Hypertension

Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises
Status: Completed Condition: Anemia, Sickle Cell

Inhaled Nitric Oxide by Oxygen Hood in Neonates
Status: Completed Condition: Respiratory Failure; Infant; Persistent Fetal Circulation

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ino
INOMAX
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXNo<disabled><disabled>
Ino
INOMAX
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXNo<disabled><disabled>
Ino
INOMAX
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXNo5,485,827*PED<disabled><disabled>
Ino
INOMAX
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXNo5,558,083*PED<disabled>Y<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc